Business ❯ Pharmaceuticals

Drug Pricing

Market Competition Market Access Weight Loss Drugs Discount Programs Generic Drugs Market Dynamics International Trade Pfizer Insurance Coverage AstraZeneca

Medicare Launches 18‑Month GLP‑1 Bridge to Cover Weight‑Loss Drugs

A temporary CMS payment pathway lowers monthly out‑of‑pocket costs to $50 for eligible seniors, with most drug costs borne by Medicare.

Brazilian-Made Semaglutide Pen Ozivy Now on Sale

CVS Caremark Restores Zepbound and Adds Lilly’s Foundayo to Standard Formularies

KFF Poll Finds MAHA Voters Prioritize Lower Health Care Costs Over Signature Issues

Counterfeit Keytruda Reached Mexico’s Public Hospitals, New Forensic Findings and Procurement Data Reveal

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

Democratic Report Puts TrumpRx Under Fresh Scrutiny as Analyses Question Real-World Savings

White House Unveils 'Great Healthcare Plan' With Sparse Details, Big Budget Questions

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

J&J Joins White House Drug-Price Pact, Wins Tariff Relief

Lilly Cuts Zepbound Cash Prices on LillyDirect as GLP‑1 Price Competition Deepens

Novo Nordisk Lowers Wegovy and Ozempic Cash Price to $349 and Unveils $199 Starter Offer

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Man Collapses in Oval Office During Trump Drug-Price Announcement

Trump Strikes Deals With Lilly and Novo to Cut GLP-1 Drug Costs to $350 a Month

Pharma Guest Collapses at Oval Office Drug-Pricing Event, White House Says He Is Fine

U.S. Envoy Warns of Pharma Pullout as AstraZeneca Rejects UK Drug-Price Offer

White House Unveils IVF Drug Discounts and Standalone Employer Benefits

AstraZeneca Strikes White House Drug-Price Deal, Wins Three-Year Tariff Reprieve